Our Mission Statement

NRG Oncology seeks to improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research with emphases on gender-associated malignancies including gynecologic, breast, and prostate cancers and on localized or locally advanced cancers of all types.

Our Scientific Focus

Scientific Plan and Structure Established for NRG Oncology

With the submission of the NRG Oncology grant proposal to the National Cancer Institute (NCI) on January 15, the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) took the formal step toward becoming the cancer clinical cooperative group NRG Oncology. These three groups have more than 150 years' cumulative experience in conducting practice-defining, multiinstitutional phase II and III trials sponsored primarily by the NCI, as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

Read more on the Scientific Focus page

Our Organizational Structure

Overview of Committees

The Concept Prioritization Advisory Committee, Research Strategy Committee, various scientific committees, and administrative committees, as shown in the figure below, will carry out research planning and the implementation of NRG Oncology functions.

Read more on the Organizational Structure page

Our Legacy Groups

NRG Oncology Foundation